Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1994 Apr;96(1):36–42. doi: 10.1111/j.1365-2249.1994.tb06226.x

Suppression of hen egg lysozyme-induced arthritis by intravenous antigen administration: no role in this for antigen-driven bystander suppression.

M J Jacobs 1, A E van den Hoek 1, L B van de Putte 1, W B van den Berg 1
PMCID: PMC1534522  PMID: 8149664

Abstract

The induction of tolerance, particularly by intervention before established immunity, is widely accepted. We studied the effects of intravenous (i.v.) administration of hen egg lysozyme (HEL), before as well as after immunization, on a HEL-induced arthritis. Arthritis and also cartilage destruction were almost completely suppressed when 100 micrograms HEL was injected before immunization. Antigen-specific proliferative T cell responses and IL-2 production in vitro were inhibited. Antigen-specific immunoglobulin and IgG1 titres were equal in control and tolerized mice, in contrast to lowered IgG2a titres in tolerized animals. Detailed histological studies showed that the immune complex-dependent polymorphonuclear cell phase (< 24 h after arthritis induction) was equal for control and HEL-injected mice. Only in the T cell-dependent phase of the arthritis (> 24 h), did suppression become pronounced in tolerized mice. I.v. administration of 100 micrograms HEL after immunization could only marginally reduce infiltrate and exudate, and no reduction of cartilage destruction was seen. An elegant way to interfere in an established immunity can be offered by creation of bystander suppression. We show that i.v. administration of HEL followed by triggering with HEL, at the moment either of immunization or of arthritis induction, does not reduce a methylated bovine serum albumin (BSA)-arthritis. We conclude that arthritis can be suppressed almost totally when HEL is injected intravenously before immunization. Treatment after immunization is less effective. The i.v. induced suppression is T cell-mediated and and antigen-specific: no bystander suppression circuit can be generated.

Full text

PDF
36

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aoki I., Usui M., Minami M., Dorf M. E. A genetically restricted suppressor factor that requires interaction with two distinct targets. J Immunol. 1984 Apr;132(4):1735–1740. [PubMed] [Google Scholar]
  2. Burstein H. J., Abbas A. K. In vivo role of interleukin 4 in T cell tolerance induced by aqueous protein antigen. J Exp Med. 1993 Feb 1;177(2):457–463. doi: 10.1084/jem.177.2.457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Burstein H. J., Shea C. M., Abbas A. K. Aqueous antigens induce in vivo tolerance selectively in IL-2- and IFN-gamma-producing (Th1) cells. J Immunol. 1992 Jun 15;148(12):3687–3691. [PubMed] [Google Scholar]
  4. Danon D., Goldstein L., Marikovsky Y., Skutelsky E. Use of cationized ferritin as a label of negative charges on cell surfaces. J Ultrastruct Res. 1972 Mar;38(5):500–510. doi: 10.1016/0022-5320(72)90087-1. [DOI] [PubMed] [Google Scholar]
  5. De Wit D., Van Mechelen M., Ryelandt M., Figueiredo A. C., Abramowicz D., Goldman M., Bazin H., Urbain J., Leo O. The injection of deaggregated gamma globulins in adult mice induces antigen-specific unresponsiveness of T helper type 1 but not type 2 lymphocytes. J Exp Med. 1992 Jan 1;175(1):9–14. doi: 10.1084/jem.175.1.9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Domen P. L., Muckerheide A., Michael J. G. Cationization of protein antigens. III. Abrogation of oral tolerance. J Immunol. 1987 Nov 15;139(10):3195–3198. [PubMed] [Google Scholar]
  7. Fiorentino D. F., Bond M. W., Mosmann T. R. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med. 1989 Dec 1;170(6):2081–2095. doi: 10.1084/jem.170.6.2081. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gahring L. C., Weigle W. O. The induction of peripheral T cell unresponsiveness in adult mice by monomeric human gamma-globulin. J Immunol. 1989 Oct 1;143(7):2094–2100. [PubMed] [Google Scholar]
  9. Higgins P. J., Weiner H. L. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. J Immunol. 1988 Jan 15;140(2):440–445. [PubMed] [Google Scholar]
  10. Howard M., O'Garra A., Ishida H., de Waal Malefyt R., de Vries J. Biological properties of interleukin 10. J Clin Immunol. 1992 Jul;12(4):239–247. doi: 10.1007/BF00918147. [DOI] [PubMed] [Google Scholar]
  11. Hoyne G. F., Callow M. G., Kuhlman J., Thomas W. R. T-cell lymphokine response to orally administered proteins during priming and unresponsiveness. Immunology. 1993 Apr;78(4):534–540. [PMC free article] [PubMed] [Google Scholar]
  12. Jacobs M. J., van den Hoek A. E., van de Putte L. B., van den Berg W. B. Aberrant tolerance induction with cationic antigens. Scand J Immunol. 1993 Jan;37(1):97–103. doi: 10.1111/j.1365-3083.1993.tb01670.x. [DOI] [PubMed] [Google Scholar]
  13. Jacobs M. J., van den Hoek A. E., van de Putte L. B., van den Berg W. B. Induction of tolerance by T-cell vaccination is possible beyond the area of autoimmunity: down-regulation of immunity directed to foreign protein antigens. Immunology. 1993 Dec;80(4):511–517. [PMC free article] [PubMed] [Google Scholar]
  14. Kruijsen M. W., van den Berg W. B., van de Putte L. B. Sequential alterations of periarticular structures in antigen-induced arthritis in mice. Histological observations on fibrous capsule, ligaments, bone and muscles, using whole joint sections. Br J Exp Pathol. 1983 Jun;64(3):298–305. [PMC free article] [PubMed] [Google Scholar]
  15. Kruijsen M. W., van den Berg W. B., van de Putte L. B., van den Broek W. J. Detection and quantification of experimental joint inflammation in mice by measurement of 99mTc-pertechnetate uptake. Agents Actions. 1981 Dec;11(6-7):640–642. doi: 10.1007/BF01978775. [DOI] [PubMed] [Google Scholar]
  16. Lamont A. G., Bruce M. G., Watret K. C., Ferguson A. Suppression of an established DTH response to ovalbumin in mice by feeding antigen after immunization. Immunology. 1988 May;64(1):135–139. [PMC free article] [PubMed] [Google Scholar]
  17. Lider O., Santos L. M., Lee C. S., Higgins P. J., Weiner H. L. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. II. Suppression of disease and in vitro immune responses is mediated by antigen-specific CD8+ T lymphocytes. J Immunol. 1989 Feb 1;142(3):748–752. [PubMed] [Google Scholar]
  18. Melamed D., Friedman A. Direct evidence for anergy in T lymphocytes tolerized by oral administration of ovalbumin. Eur J Immunol. 1993 Apr;23(4):935–942. doi: 10.1002/eji.1830230426. [DOI] [PubMed] [Google Scholar]
  19. Miller A., Lider O., Roberts A. B., Sporn M. B., Weiner H. L. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):421–425. doi: 10.1073/pnas.89.1.421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Miller A., Lider O., Weiner H. L. Antigen-driven bystander suppression after oral administration of antigens. J Exp Med. 1991 Oct 1;174(4):791–798. doi: 10.1084/jem.174.4.791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Mowat A. M., Lamont A. G., Parrott D. M. Suppressor T cells, antigen-presenting cells and the role of I-J restriction in oral tolerance to ovalbumin. Immunology. 1988 May;64(1):141–145. [PMC free article] [PubMed] [Google Scholar]
  22. Muckerheide A., Domen P. L., Michael J. G. Cationization of protein antigens. II. Alteration of regulatory properties. J Immunol. 1987 May 1;138(9):2800–2804. [PubMed] [Google Scholar]
  23. Mukasa A., Itoh M., Tokunaga Y., Hiramine C., Hojo K. Inhibition of a novel model of murine experimental autoimmune orchitis by intravenous administration with a soluble testicular antigen: participation of CD8+ regulatory T cells. Clin Immunol Immunopathol. 1992 Feb;62(2):210–219. doi: 10.1016/0090-1229(92)90074-x. [DOI] [PubMed] [Google Scholar]
  24. Myers L. K., Stuart J. M., Seyer J. M., Kang A. H. Identification of an immunosuppressive epitope of type II collagen that confers protection against collagen-induced arthritis. J Exp Med. 1989 Dec 1;170(6):1999–2010. doi: 10.1084/jem.170.6.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Parish N. M., Roitt I. M., Cooke A. Phenotypic characteristics of cells involved in induced suppression to murine experimental autoimmune thyroiditis. Eur J Immunol. 1988 Sep;18(9):1463–1467. doi: 10.1002/eji.1830180924. [DOI] [PubMed] [Google Scholar]
  26. Peng H. J., Turner M. W., Strobel S. The kinetics of oral hyposensitization to a protein antigen are determined by immune status and the timing, dose and frequency of antigen administration. Immunology. 1989 Jul;67(3):425–430. [PMC free article] [PubMed] [Google Scholar]
  27. Sakato N., Fujio H. Suppression of the delayed-type hypersensitivity response to hen egg white lysozyme (HEL) by HEL peptides in a genetically high-responder mouse strain: evidence for requirement of the loop structure for induction of suppressor T cells. Cell Immunol. 1986 Jun;100(1):66–78. doi: 10.1016/0008-8749(86)90007-9. [DOI] [PubMed] [Google Scholar]
  28. Singh V. K., Kalra H. K., Yamaki K., Shinohara T. Suppression of experimental autoimmune uveitis in rats by the oral administration of the uveitopathogenic S-antigen fragment or a cross-reactive homologous peptide. Cell Immunol. 1992 Jan;139(1):81–90. doi: 10.1016/0008-8749(92)90101-t. [DOI] [PubMed] [Google Scholar]
  29. Thompson H. S., Staines N. A. Could specific oral tolerance be a therapy for autoimmune disease? Immunol Today. 1990 Nov;11(11):396–399. doi: 10.1016/0167-5699(90)90158-6. [DOI] [PubMed] [Google Scholar]
  30. Thompson H. S., Staines N. A. Suppression of collagen-induced arthritis with pergastrically or intravenously administered type II collagen. Agents Actions. 1986 Dec;19(5-6):318–319. doi: 10.1007/BF01971237. [DOI] [PubMed] [Google Scholar]
  31. Trentham D. E., Dynesius-Trentham R. A., Orav E. J., Combitchi D., Lorenzo C., Sewell K. L., Hafler D. A., Weiner H. L. Effects of oral administration of type II collagen on rheumatoid arthritis. Science. 1993 Sep 24;261(5129):1727–1730. doi: 10.1126/science.8378772. [DOI] [PubMed] [Google Scholar]
  32. Whitacre C. C., Gienapp I. E., Orosz C. G., Bitar D. M. Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy. J Immunol. 1991 Oct 1;147(7):2155–2163. [PubMed] [Google Scholar]
  33. van den Berg W. B., Kruijsen M. W., van de Putte L. B., van Beusekom H. J., van der Sluis-van der Pol M., Zwarts W. A. Antigen-induced and zymosan-induced arthritis in mice: studies on in vivo cartilage proteoglycan synthesis and chondrocyte death. Br J Exp Pathol. 1981 Jun;62(3):308–316. [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES